1. Home
  2. BMEA vs UBFO Comparison

BMEA vs UBFO Comparison

Compare BMEA & UBFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

HOLD

Current Price

$1.38

Market Cap

96.9M

Sector

Health Care

ML Signal

HOLD

Logo United Security Bancshares

UBFO

United Security Bancshares

HOLD

Current Price

$10.34

Market Cap

154.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMEA
UBFO
Founded
2017
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
96.9M
154.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BMEA
UBFO
Price
$1.38
$10.34
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$8.71
N/A
AVG Volume (30 Days)
1.6M
59.2K
Earning Date
11-04-2025
01-26-2026
Dividend Yield
N/A
4.64%
EPS Growth
N/A
N/A
EPS
N/A
0.65
Revenue
N/A
$46,495,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$15.91
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$7.32
52 Week High
$4.59
$10.53

Technical Indicators

Market Signals
Indicator
BMEA
UBFO
Relative Strength Index (RSI) 55.16 66.95
Support Level $0.95 $10.19
Resistance Level $1.42 $10.53
Average True Range (ATR) 0.14 0.19
MACD 0.03 0.01
Stochastic Oscillator 72.13 74.29

Price Performance

Historical Comparison
BMEA
UBFO

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.

About UBFO United Security Bancshares

United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.

Share on Social Networks: